Najjar, O., Varghese, A., Shahi, M., Vang, R., Gaillard, S., Smith, T., & Fader, A. N. (2020). Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report. Gynecologic Oncology Reports, 32. https://doi.org/10.1016/j.gore.2020.100555

Najjar, O., A. Varghese, M. Shahi, R. Vang, S. Gaillard, T. Smith, and A. N. Fader. “Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report.” Gynecologic Oncology Reports 32 (May 1, 2020). https://doi.org/10.1016/j.gore.2020.100555.

Najjar O, Varghese A, Shahi M, Vang R, Gaillard S, Smith T, et al. Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report. Gynecologic Oncology Reports. 2020 May 1;32.

Najjar, O., et al. “Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report.” Gynecologic Oncology Reports, vol. 32, May 2020. Scopus, doi:10.1016/j.gore.2020.100555.

Najjar O, Varghese A, Shahi M, Vang R, Gaillard S, Smith T, Fader AN. Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case report. Gynecologic Oncology Reports. 2020 May 1;32.